Decreased GSK3βtyr216 and increased GSK3βser9 levels have been reported in cervical cancer tissues, which indicates that activated GSK3β may play some roles in the inhibition of tumorigenesis [38]. The gene discussed is GSK3B; the disease is cervical carcinoma.